1,355 pharmaceutical and medication recalls tracked. Stay informed about FDA drug safety alerts, prescription medications, over-the-counter drugs, and dietary supplements.
Looking for a specific drug? Use the search page to find recalls by medication name, manufacturer, or NDC number.
Olympus Corporation of the Americas recalled the Bronchovideoscope BF-1TQ170 on September 11, 2025. The recall affects 2,092 units distributed outside the U.S. Additional instructions for safe use with laser and other therapies prompted this action.
Olympus Corporation of the Americas recalled 1,007 bronchofiberscopes on September 11, 2025, due to safety concerns related to their use with laser and high-frequency therapy equipment. The recall affects devices distributed nationwide in the U.S. and involves additional instructions for safe use.
Medline Industries recalled 8,267,150 saline flush syringes on September 11, 2025. The syringes may not meet the required concentration of sodium chloride. Consumers and healthcare providers must stop using these products immediately.
Theken Companies recalled 409 Bipolar Hip Implants on September 11, 2025. The devices failed transit testing and may have compromised sterile barriers. Patients and healthcare providers must stop using the implants immediately.
Olympus Corporation of the Americas recalled 1,473 EVIS EXERA II Bronchoscopes on September 11, 2025. The recall addresses critical updates to the instructions for use when combined with laser and coagulation therapies. Healthcare professionals must stop using the device immediately and follow the manufacturer's instructions.
Olympus Corporation of the Americas recalled the BF-H1100 bronchovideoscope on September 11, 2025, due to safety concerns when used with certain medical equipment. The recall affects 1,867 units distributed outside the U.S. Patients and healthcare providers should stop using the device immediately.
Olympus Corporation of the Americas recalled 3,046 units of its EVIS EXERA III bronchoscope BF-P190 on September 11, 2025. The recall addresses safety concerns regarding the use of the bronchoscope with laser and high-frequency therapy equipment. Healthcare providers must stop using this device immediately.
Abbott recalled 1,958 TactiFlex Sensor Enabled Ablation Catheters on September 10, 2025. The recall follows reports of tip detachment during removal from packaging. Patients and healthcare providers must stop using the device immediately.
Abbott recalled 399 TactiFlex Sensor Enabled Ablation Catheters on September 10, 2025. The recall stems from a limited number of incidents where catheter tips detached during removal from packaging. Patients and healthcare providers must stop using the device immediately and follow recall instructions.
Abbott recalled 3,403 TactiFlex Sensor Enabled Ablation Catheters due to potential tip detachment during removal. The recall affects medical devices distributed worldwide. Patients and healthcare providers must stop using the device immediately.
Abbott recalled 11,805 TactiFlex Sensor Enabled Ablation Catheters on September 10, 2025. The recall follows reports of tip detachment during catheter removal from packaging. Patients and healthcare providers must stop using the device immediately.
Biomet recalled 40 units of Juggerknot Mini Soft Anchors on September 9, 2025. The recall stems from a labeling error where the carton contains 1.4mm Short devices instead of the labeled 1.0mm Mini products. Patients and healthcare providers must stop using these devices immediately.
BioPro recalled 147 femoral head components on September 9, 2025. A packaging defect may compromise sterility, increasing infection risk. The recall affects models distributed in Texas and Michigan.
MedicalCommunications GmbH recalled 474 units of HEYEX PACS software on September 9, 2025. The software may inaccurately report measured values, posing risks to patient care. Users should stop using the software immediately and follow recall instructions.
BioPro recalled 147 femoral heads on September 9, 2025, due to a packaging defect. The defect threatens the sterility of the device, which could lead to infection if implanted. Healthcare providers and patients must stop using these devices immediately.
BioPro recalled 147 bipolar heads on September 9, 2025, due to a potential packaging issue. The defect may compromise the sterile barrier, increasing infection risks if implanted. Healthcare providers and patients should stop using these devices immediately.
NOXBOX recalled 1,667 Nitric Oxide Delivery Systems on September 9, 2025. The recall stems from dangerous dose fluctuations that could occur under specific device settings. Healthcare providers and patients should stop using the device immediately.
Draeger recalled 223 Atlan A350XL anesthesia workstations on September 9, 2025. The devices may fail during mechanical ventilation, posing serious health risks. The recall affects states across the U.S. and several countries worldwide.
NOXBOX recalled 1,667 Nitric Oxide Delivery Systems on September 9, 2025. The recall follows reports of internal faults caused by rapid button selections. The company advises patients and healthcare providers to stop using the device immediately.
Draeger recalled 530 Atlan A350 anesthesia workstations due to potential ventilation failures. The recall occurred on September 9, 2025, after reports of critical device malfunctions during use. Patients and healthcare providers must stop using the device immediately.
BioPro recalled 147 units of Endo Heads on September 9, 2025. A packaging issue may compromise the sterile barrier, leading to infection risk. Healthcare providers and patients should stop using the devices immediately.
Iantrek recalled 1,262 units of the Cyclopen Microinterventional Cyclodialysis System on September 6, 2025. The recall stems from a risk of compromised sterile packaging that could affect patient safety. Health care providers and patients must stop using the device immediately and follow manufacturer instructions.
Iantrek recalled 198 C-Rex UNO Microinterventional Goniotomy Instruments on September 6, 2025, due to compromised sterile packaging. The recall affects the model CRX-120 distributed in multiple U.S. states. Healthcare providers and patients must stop using these instruments immediately.
Sandoz Inc. recalled 263 vials of Cyclophosphamide Injection on September 5, 2025. The recall follows cGMP deviations related to temperature excursions during transportation. Healthcare providers and consumers must stop using the product immediately.
Receive immediate notifications when medications you care about are recalled. Stay safe with timely FDA drug safety alerts.